Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-05-10
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For Medicines With The Active Ingredient Triptorelin (atc Code: L02ae04 And H01ca07). 2026-05-10
Germany Drug Discount Agreements From January 1st, 2026 On Various Active Ingredients As Part Of An Open House Procedure 2026-05-10
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For Medicines With The Active Ingredient Somatropin (atc Code: H01ac01). 2026-05-10
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For Drugs With The Active Ingredient Pazopanib (atc Code: L01ex03). 2026-05-10
Germany Conclusion Not Excluding The Pharmaceutical Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Lactulose (atc Code According To Who 2026-05-10
Germany Conclusion Not Excluding The Discount Agreement For Pharmaceuticals According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Colistin (atc Code According To Who 2026-05-10
Finland Disposable And Reusable Gynecological Supplies 2026-05-10
Poland Delivery Of Diagnostic Reagents For Immunohematological Tests Performed Using Automatic And Manual Methods, Reference Blood Cells, Kits For Daily Quality Control Of Tests, Along With The Lease Of Two Analyzers And A Manual Backup Set (min. 1 Microcard Cen 2026-05-10
Poland Delivery Of Diagnostic Materials 2026-05-10
Whats app